SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-000306
Filing Date
2017-02-01
Accepted
2017-02-01 08:30:51
Documents
3
Period of Report
2017-02-01
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K s105202_8k.htm 8-K 23080
2 EXHIBIT 99.1 s105202_ex99-1.htm EX-99.1 13894
3 GRAPHIC logo.jpg GRAPHIC 6020
  Complete submission text file 0001615774-17-000306.txt   46506
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 17563187
SIC: 2836 Biological Products, (No Diagnostic Substances)